Literature DB >> 11289773

Emergence and spread of low-level mupirocin resistance in methicillin-resistant Staphylococcus aureus isolated from a community hospital in Japan.

H Watanabe1, H Masaki, N Asoh, K Watanabe, K Oishi, A Furumoto, S Kobayashi, A Sato, T Nagatake.   

Abstract

The objective of this study was to investigate the state of mupirocin resistance in methicillin-resistant Staphylococcus aureus (MRSA) in a community hospital in Japan. Ninety strains of MRSA were isolated from the respiratory tract of 56 patients (group I, Jun 1990-Aug 1996) before introduction of mupirocin in Japan, which were compared with 168 strains from 48 patients (group II, Sept 1996-Jan 1998) and 146 strains from 85 patients (group III, Feb 1999-Dec 1999) isolated after introduction of mupirocin. Comparisons were made by determining the minimum inhibitory concentrations (MIC) against nine antibiotics. Fifty-five MRSA isolates from 27 patients [13 (27.1%) of 48 in group II and 14 (16.5%) of 85 in group III] after introduction of mupirocin showed low-level resistance to mupirocin (MIC, 6.25 to 50 microg/ml) but the remaining isolates were sensitive to mupirocin (MIC < or =3.13 microg/ml). Most patients colonized with low-level mupirocin-resistant MRSA were elderly (> or =65 years of age), on total parenteral nutrition or nasal feeding and had other underlying diseases. The proportion of patients colonized with low-level mupirocin-resistant MRSA following repeated use of mupirocin was higher in patients of group II than those of group III. Molecular typing by pulsed-field gel electrophoresis (PFGE) demonstrated that the pattern of 13 MRSA isolates from 13 patients of group II consisted of three patterns (A, B, C) with predominance of pattern A, while the pattern of 13 MRSA isolates from 13 patients of group III consisted of three patterns (A, C, D) with predominance of patterns A and D. Our results indicated that resistance of MRSA to mupirocin remains at a low level at present in Japan. However, we should be aware of the possible emergence of MRSA highly resistant to mupirocin in the future. Copyright 2001 The Hospital Infection Society.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11289773     DOI: 10.1053/jhin.2000.0931

Source DB:  PubMed          Journal:  J Hosp Infect        ISSN: 0195-6701            Impact factor:   3.926


  7 in total

1.  Low concentrations of mupirocin in the pharynx following intranasal application may contribute to mupirocin resistance in methicillin-resistant Staphylococcus aureus.

Authors:  H Watanabe; H Masaki; N Asoh; K Watanabe; K Oishi; S Kobayashi; A Sato; R Sugita; T Nagatake
Journal:  J Clin Microbiol       Date:  2001-10       Impact factor: 5.948

2.  Efficacy of skin and nasal povidone-iodine preparation against mupirocin-resistant methicillin-resistant Staphylococcus aureus and S. aureus within the anterior nares.

Authors:  Michele J Anderson; Maren L David; Matt Scholz; Sally J Bull; Dan Morse; Michelle Hulse-Stevens; Marnie L Peterson
Journal:  Antimicrob Agents Chemother       Date:  2015-03-02       Impact factor: 5.191

3.  Analysis of mupirocin resistance and fitness in Staphylococcus aureus by molecular genetic and structural modeling techniques.

Authors:  Julian Gregston Hurdle; Alexander John O'Neill; Eileen Ingham; Colin Fishwick; Ian Chopra
Journal:  Antimicrob Agents Chemother       Date:  2004-11       Impact factor: 5.191

4.  Nasal Carriage of Staphylococcus aureus As a Risk Factor for Skin and Soft Tissue Infections.

Authors:  J. John Weems; Luna B. Beck
Journal:  Curr Infect Dis Rep       Date:  2002-10       Impact factor: 3.725

5.  Molecular analysis of isoleucyl-tRNA synthetase mutations in clinical isolates of methicillin-resistant Staphylococcus aureus with low-level mupirocin resistance.

Authors:  Jin Ah Yang; Dae Won Park; Jang Wook Sohn; In Seok Yang; Kyung Hyun Kim; Min Ja Kim
Journal:  J Korean Med Sci       Date:  2006-10       Impact factor: 2.153

6.  Phenotypic and molecular characterization of Staphylococcus aureus isolates expressing low- and high-level mupirocin resistance in Nigeria and South Africa.

Authors:  Adebayo O Shittu; Edet E Udo; Johnson Lin
Journal:  BMC Infect Dis       Date:  2009-01-28       Impact factor: 3.090

7.  Advancing age and the risk of nasal carriage of Staphylococcus aureus among patients on long-term hospital-based hemodialysis.

Authors:  Anil K Saxena; B R Panhotra; Rajan Chopra
Journal:  Ann Saudi Med       Date:  2004 Sep-Oct       Impact factor: 1.526

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.